$BLRX News Article - BioLineRx Announces Poster Presentation on Economic Model Data for APHEXDA (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024
https://marketwirenews.com/news-releases/biol...08487.html